Triple
T7872154
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Children's Health Defense |
E182761
|
entity |
| Predicate | regulatoryAttentionFrom |
P36111
|
FINISHED |
| Object | U.S. Food and Drug Administration |
E13297
|
NE FINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: U.S. Food and Drug Administration | Statement: [Children's Health Defense, regulatoryAttentionFrom, U.S. Food and Drug Administration]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: U.S. Food and Drug Administration Context triple: [Children's Health Defense, regulatoryAttentionFrom, U.S. Food and Drug Administration]
-
A.
Food and Drug Administration
chosen
The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
-
B.
Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
-
C.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
D.
Office of Regulatory Affairs
The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
-
E.
FDA CFSAN
FDA CFSAN is the U.S. Food and Drug Administration’s center responsible for regulating the safety, labeling, and nutritional quality of foods, dietary supplements, and cosmetics.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: regulatoryAttentionFrom Context triple: [Children's Health Defense, regulatoryAttentionFrom, U.S. Food and Drug Administration]
-
A.
regulationAtIssue
Indicates that a specific regulation is the subject of concern, dispute, or analysis in the given context.
-
B.
regulatoryAudience
Indicates that something is intended for, directed toward, or relevant to a regulatory body or oversight authority as its audience.
-
C.
regulatoryIssues
Indicates that there are regulatory concerns, non-compliance, or potential violations associated with the related entity or activity.
-
D.
regulatoryResponse
chosen
Indicates a reaction, decision, or adjustment made by a regulatory body in response to a particular event, condition, or entity’s behavior.
-
E.
regulatoryType
Indicates the specific kind or category of regulatory control, rule, or oversight that applies in the given relationship.
- F. None of above.
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69ca82894d9081908a832bfce71a4714 |
completed | March 30, 2026, 2:02 p.m. |
| NER | Named-entity recognition | batch_69cb39a6d93881908d68386e49bea1e3 |
completed | March 31, 2026, 3:04 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69cb5b6bc7248190adbf4377c52e16a9 |
completed | March 31, 2026, 5:28 a.m. |
| PD | Predicate disambiguation | batch_69cae928e1b88190b0620f4c4f03bc7d |
completed | March 30, 2026, 9:20 p.m. |
Created at: March 30, 2026, 4:56 p.m.